Evidence map›Paper›PMID 42242207›Full record

ArticleCell host & microbe2026

Intracellular acidification by microbiota-derived valeric acid facilitates trans-kingdom ecology limiting Candida parapsilosis colonization.

Keiko Yasuma-Mitobe, Chen Liao, Tibor Németh, Kevin Byrne, Audrey Billips, Ruben Jose Jesus Faustino Ramos, Cristine Nicole Salinas, Eric Chan, Martina Perissinoto, Sophia Adami-Sampson and 9 more

Abstract read
In one paragraph

Article in Cell host & microbe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Keiko Yasuma-MitobeInfectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Chen LiaoDepartment of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Tibor NémethDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged 6720, Hungary.
Kevin ByrneSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.
Audrey BillipsInfectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ruben Jose Jesus Faustino RamosDonald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cristine Nicole SalinasInfectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; The Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.
Eric ChanMolecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Martina PerissinotoTechnical and Quality Department, SILA S. p. A. Advanced Nutrition, Noale 30033, Italy.
Sophia Adami-SampsonLaboratory of Environmental Microbiology, Rockefeller University, New York, NY 10065, USA.
Ayesha SalmanInfectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ashley M SidebottomDuchossois Family Institute, University of Chicago, Chicago, IL 60637, USA.
George PlitasImmunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Geraldine ButlerSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.
Justin R CrossDonald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Eric G PamerLaboratory of Environmental Microbiology, Rockefeller University, New York, NY 10065, USA.
Attila GácserDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged 6720, Hungary.
Joao B XavierComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Tobias M HohlInfectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: hohlt@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal nicheP01AI179406 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TOBIAS M HOHL · 2024 to 2026
$9.9M
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSR37AI093808 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TOBIAS M HOHL · 2021 to 2026
$4.2M
Unraveling the ecology of intestinal fungal expansion in immunocompromised patients through computational modeling and machine learningR00AI175599 · NIAID · DARTMOUTH COLLEGE · PI LIAO, CHEN · 2025 to 2025
$247k
Unraveling the ecology of intestinal fungal expansion in immunocompromised patients through computational modeling and machine learningK99AI175599 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI LIAO, CHEN · 2024 to 2025
$170k
NCI NIH HHS P30 CA008748NIAID NIH HHS K99 AI175599NIAID NIH HHS P01 AI179406NIAID NIH HHS R00 AI175599NIAID NIH HHS R37 AI093808
6 · The paper itself

Abstract

In hematopoietic cell transplant (HCT) patients, intestinal Candida parapsilosis expansion and translocation can cause life-threatening candidemia, yet whether commensal intestinal bacteria prevent Candida expansion remains incompletely defined. Here, we trained a machine learning model on supernatant metabolomic profiles of Lachnospiraceae to identify bacteria-derived inhibitors of fungal growth, identifying valeric and butyric acids as top hits. Fecal samples from HCT patients supported this association, with valeric and butyric acid levels inversely correlating with C. parapsilosis growth. In cell culture and mice, valeric acid inhibited C. parapsilosis growth by increasing intracellular acidification. Administration of glycerol valerate, or free or microencapsulated valeric acid, to release valeric acid along the entire intestinal tract blunted C. parapsilosis growth at murine intestinal sites where valeric acid was detected. Thus, machine learning identified a mechanistic driver of trans-kingdom ecology limiting C. parapsilosis intestinal expansion and may inform strategies to reduce patient risk of candidiasis.

Indexed as

Candida parapsilosisGastrointestinal MicrobiomePentanoic AcidsAnimalsCandidiasisFecesHumansHydrogen-Ion ConcentrationIntestinesMachine LearningMicen-pentanoic acidPentanoic AcidsCandida parapsilosiscolonizationecologyfungusintestineLachnospiraceaemachine learningpH homeostasisshort-chain fatty acidsvaleric acid

Identifiers

PMID42242207
PMCPMC13426287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.